Diversified Healthcare Trust

DHC · NASDAQ

$7.72+$0.35 (+4.75%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $7.37

DHC analyst rating

BuyConsensus of 3 analysts over the last 12 months. 67% rate it a buy.

Strong buy0
Buy2
Hold1
Underperform0
Sell0

12-month price target · 5 analysts

Average $10.35 (+34.1% upside)

Low: $8.08
Now: $7.72
High: $12.07

Upgrades and downgrades

The latest rating actions, newest first

DHC analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
RBC Capital	Jun 18, 2026	Maintains	Sector Perform	$6.00 → $8.00	58%
B. Riley Securities	Jun 9, 2026	Maintains	Buy	$8.50 → $11.00	48%
Maxim Group	Jun 3, 2026	Maintains	Buy	$10.00 → $10.50	49%
Maxim Group	Apr 27, 2026	Initiates	Buy	$9.50	49%
B. Riley Securities	Mar 3, 2026	Maintains	Buy	$6.50 → $8.50	48%
RBC Capital	Mar 2, 2026	Maintains	Sector Perform	$5.00 → $6.00	58%
B. Riley Securities	Dec 15, 2025	Maintains	Buy	$5.50 → $6.50	48%
RBC Capital	Nov 13, 2025	Upgrade	Underperform → Sector Perform	$3.00 → $5.00	58%

The case for and against

Updated Feb 5, 2025

Bull case

Diversified Healthcare Trust (DHC) exhibits a positive outlook primarily due to expected recovery in its SHOP segment, which is anticipated to generate improved operating results by the second half of 2024. The company is strategically focusing on optimizing its balance sheet through asset sales and refinancing initiatives that are projected to enhance liquidity and reduce debt costs. While annual funds from operations (AFFO) are expected to remain negative until at least 2025, a notable trend towards improvement may lead to a break-even point by 2026, underscoring a cautiously optimistic financial trajectory.

Bear case

Diversified Healthcare Trust faces significant risks stemming from general economic and regulatory trends, which could adversely affect the profitability of healthcare providers and impede the company's operational effectiveness in the evolving seniors housing market. The company's health is further compromised by an elevated net debt to EBITDA ratio of 10.2x, indicating high leverage that may constrain financial flexibility and resource allocation for necessary capital expenditure projects. Additionally, the recent transition of operators at approximately 50% of its senior housing communities may hinder the recovery of the SHOP segment, making it challenging for the company to navigate uncertainties moving forward.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.